VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $509,000 | +47.1% | 21,950 | +0.9% | 0.07% | +50.0% |
| Q1 2018 | $346,000 | -24.0% | 21,750 | -0.5% | 0.05% | -23.3% |
| Q4 2017 | $455,000 | +35.0% | 21,850 | -7.7% | 0.06% | +22.4% |
| Q3 2017 | $337,000 | +26.2% | 23,675 | +55.0% | 0.05% | +11.4% |
| Q2 2017 | $267,000 | +107.0% | 15,275 | +32.3% | 0.04% | +100.0% |
| Q1 2017 | $129,000 | -60.2% | 11,550 | -12.6% | 0.02% | -59.3% |
| Q3 2016 | $324,000 | – | 13,208 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |